document.write("
"); document.write("
Hoerger,\ T.J.*\ ; Hilscher,\ R.*\ ; Neuwahl,\ S.*\ ; Kaufmann,\ M.B.*\ ; Shao,\ H.*\ ; Laxy,\ M.\ ; Cheng,\ Y.J.*\ ; Benoit,\ S.*\ ; Chen,\ H.*\ ; Anderson,\ A.*\ ; Craven,\ T.*\ ; Yang,\ W.*\ ; Cintina,\ I.*\ ; Staimez,\ L.*\ ; Zhang,\ P.*
"); document.write("
A new type 2 diabetes microsimulation model to estimate long-term health outcomes, costs, and cost-effectiveness.
"); document.write("
Value Health 26, 1372-1380 (2023)
"); document.write("
"); document.write("
"); document.write("
Seidl,\ H.\ ; Schunk,\ M.*\ ; Le,\ L.*\ ; Syunyaeva,\ Z.*\ ; Streitwieser,\ S.*\ ; Berger,\ U.*\ ; Mansmann,\ U.*\ ; Szentes,\ B.L.\ ; Bausewein,\ C.*\ ; Schwarzkopf,\ L.
"); document.write("
Cost-effectiveness of a specialized breathlessness service versus usual care for patients with advanced diseases.
"); document.write("
Value Health 26, 81-90 (2023)
"); document.write("
"); document.write("
"); document.write("
Böckmann,\ D.\ ; Szentes,\ B.L.\ ; Schultz,\ K.*\ ; Nowak,\ D.*\ ; Schuler,\ M.*\ ; Schwarzkopf,\ L.
"); document.write("
Cost-effectiveness of pulmonary rehabilitation in patients with bronchial asthma: An analysis of the EPRA randomized controlled trial.
"); document.write("
Value Health 24, 1254-1262 (2021)
"); document.write("
"); document.write("
"); document.write("
Laxy,\ M.\ ; Becker,\ J.\ ; Kähm,\ K.\ ; Holle,\ R.\ ; Peters,\ A.\ ; Thorand,\ B.\ ; Schwettmann,\ L.\ ; Karl,\ F.
"); document.write("
Utility decrements associated with diabetes and related complications: Estimates from a population-based study in Germany.
"); document.write("
Value Health 24, 274-280 (2021)
"); document.write("
"); document.write("
"); document.write("
Shao,\ H.*\ ; Laxy,\ M.\ ; Gregg,\ E.W.*\ ; Albright,\ A.*\ ; Zhang,\ P.*
"); document.write("
Cost-effectiveness of the new 2018 American college of physicians glycemic control guidance statements among US adults with type 2 diabetes.
"); document.write("
Value Health 24, 227-235 (2021)
"); document.write("
"); document.write("
"); document.write("
Maqhuzu,\ P.N.\ ; Szentes,\ B.L.\ ; Kreuter,\ M.*\ ; Bahmer,\ T.*\ ; Kahn,\ N.C.*\ ; Claussen,\ M.*\ ; Holle,\ R.\ ; Schwarzkopf,\ L.
"); document.write("
Predictors of health-related quality of life decline in intersitial lung disease using the K-bild questionnaire.
"); document.write("
Value Health 23, S360-S360 (2020)
"); document.write("
"); document.write("
"); document.write("
Kirsch,\ F.\ ; Schramm,\ A.*\ ; Schwarzkopf,\ L.\ ; Szentes,\ B.L.\ ; Lutter,\ J.\ ; Huber,\ M.B.\ ; Leidl,\ R.
"); document.write("
Influence of COPD severity and its comorbidities on direct and indirect costs: Results from the LQ-DMP study.
"); document.write("
Value Health 22, S876-S876 (2019)
"); document.write("
"); document.write("
"); document.write("
Maqhuzu,\ P.N.\ ; Kreuter,\ M.*\ ; Schwarzkopf,\ L.
"); document.write("
Cost of healthcare resource utilization in interstitial lung diseases in Germany in 2017.
"); document.write("
Value Health 22, S845-S845 (2019)
"); document.write("
"); document.write("
"); document.write("
Szentes,\ B.L.\ ; Schwarzkopf,\ L.\ ; Schüler,\ M.*\ ; Lehbert,\ N.*\ ; Nowak,\ D.*\ ; Wittmann,\ M.*\ ; Faller,\ H.*\ ; Schultz,\ K.*
"); document.write("
The suitablility of the EQ-5D-5L in asthma patients.
"); document.write("
Value Health 22, S882-S882 (2019)
"); document.write("
"); document.write("
"); document.write("
Arnold,\ M.\ ; Quante,\ A.S.
"); document.write("
Personalized mammography screening and screening adherence-A simulation and economic evaluation.
"); document.write("
Value Health 21, 799-808 (2018)
"); document.write("
"); document.write("
"); document.write("
Szentes,\ B.L.\ ; Kirsch,\ F.\ ; Schramm,\ A.*\ ; Schwarzkopf,\ L.\ ; Leidl,\ R.
"); document.write("
Association between severe, moderate and mild exacerbations with generic health-related quality of life in COPD patients.
"); document.write("
Value Health 21, S419-S419 (2018)
"); document.write("
"); document.write("
"); document.write("
Walter,\ J.\ ; Schwarzkopf,\ L.
"); document.write("
First insights into comparing expenditures for targeted therapy and survival in NSCLC.
"); document.write("
Value Health 21, S35-S35 (2018)
"); document.write("
"); document.write("
"); document.write("
Arnold,\ M.*\ ; Quante,\ A.S.
"); document.write("
Risk-stratified breast cancer screening and non-adherence in Germany.
"); document.write("
Value Health 20, A442-A442 (2017)
"); document.write("
"); document.write("
"); document.write("
Hoogendoorn,\ M.*\ ; Feenstra,\ T.L.*\ ; Asukai,\ Y.*\ ; Briggs,\ A.H.*\ ; Hansen,\ R.N.*\ ; Leidl,\ R.\ ; Risebrough,\ N.*\ ; Samyshkin,\ Y.*\ ; Wacker,\ M.*\ ; Rutten-van Mölken,\ M.P.*
"); document.write("
External validation of health economic decision models for chronic obstructive pulmonary disease (COPD): Report of the third COPD modeling meeting.
"); document.write("
Value Health 20, 397-403 (2017)
"); document.write("
"); document.write("
"); document.write("
Kirsch,\ F.*\ ; Becker,\ C.\ ; Maier,\ W.\ ; Schramm,\ A.*
"); document.write("
Effects of adherence to pharmacological secondary prevention after myocardial infarction on healthcare expenditures.
"); document.write("
Value Health 20, A609-A609 (2017)
"); document.write("
"); document.write("
"); document.write("
Laxy,\ M.\ ; Wilson,\ E.C.F.*\ ; Boothby,\ C.E.*\ ; Griffin,\ S.J.*
"); document.write("
Incremental costs and cost-effectiveness of intensive treatment in individuals with type 2 diabetes detected by screening in the ADDITION-UK trial: An update with empirical trial-based cost data.
"); document.write("
Value Health 20, 1288-1298 (2017)
"); document.write("
"); document.write("
"); document.write("
Leidl,\ R.\ ; Reitmeir,\ P.
"); document.write("
An experience-based value set for the EQ-5D-5L in Germany.
"); document.write("
Value Health 20, 1150-1156 (2017)
"); document.write("
"); document.write("
"); document.write("
Seidl,\ H.\ ; Hunger,\ M.\ ; Meisinger,\ C.\ ; Kirchberger,\ I.\ ; Kuch,\ B.*\ ; Leidl,\ R.\ ; Holle,\ R.
"); document.write("
The 3-year cost-effectiveness of a nurse-based case management versus usual care for elderly patients with myocardial infarction: Results from the KORINNA follow-up study.
"); document.write("
Value Health 20, 441-450 (2017)
"); document.write("
"); document.write("
"); document.write("
Szentes,\ B.L.\ ; Kreuter,\ M.*\ ; Bahmer,\ T.*\ ; Birring,\ S.*\ ; Claussen,\ M.*\ ; Waelscher,\ J.*\ ; Schwarzkopf,\ L.
"); document.write("
Quality of life assessment in ILD - a comparison of\  EQ-5D with the disease-specific K-bild.
"); document.write("
Value Health 20, A649-A649 (2017)
"); document.write("
"); document.write("
"); document.write("
Walter,\ J.\ ; Tufman,\ A.*\ ; Holle,\ R.\ ; Schwarzkopf,\ L.
"); document.write("
Comparison of costs and care of lung cancer patient at the end-of-life in Germany depending on the tome of survival after diagnosis.
"); document.write("
Value Health 20, A511-A511 (2017)
"); document.write("
"); document.write("
"); document.write("
Arnold,\ M.*\ ; Quante,\ A.S.
"); document.write("
Personalized mammography screening and screening adherence - a simulation of cost-effectiveness.
"); document.write("
Value Health 19, A738-A738 (2016)
"); document.write("
"); document.write("
"); document.write("
Danner,\ M.*\ ; Müller,\ D.*\ ; Schmutzler,\ R.K.*\ ; Rhiem,\ K.*\ ; Engel,\ C.*\ ; Stollenwerk,\ B.\ ; Stock,\ S.*\ ; Wassermann,\ K.*
"); document.write("
Economic modeling of risk-adapted screen-and-treat strategies in women at high-risk for breast or ovarian cancer.
"); document.write("
Value Health 19, A737-A738 (2016)
"); document.write("
"); document.write("
"); document.write("
Hoogendoorn,\ M.*\ ; Feenstra,\ T.*\ ; Asukai,\ Y.*\ ; Briggs,\ A.*\ ; Borg,\ S.*\ ; dal Negro,\ R.*\ ; Hansen,\ R.N.*\ ; Jansson,\ S.A.*\ ; Leidl,\ R.\ ; Risebrough,\ N.*\ ; Samyshkin,\ Y.*\ ; Wacker,\ M.\ ; Rutten van-Mölken,\ M.*
"); document.write("
Patient heterogeneity in health economic decision models for Chronic Obstructive Pulmonary Disease: Are current models suitable to evaluate personalized medicine?.
"); document.write("
Value Health 19, 800-810 (2016)
"); document.write("
"); document.write("
"); document.write("
Kirsch,\ F.
"); document.write("
Economic evaluations of multicomponent disease management programs with Markov models: A systematic review.
"); document.write("
Value Health 19, 1039-1054 (2016)
"); document.write("
"); document.write("
"); document.write("
Leidl,\ R.\ ; Reitmeir,\ P.
"); document.write("
Analyzing a German index for the EQ-5D-5L based on experienced health.
"); document.write("
Value Health 19, A386-A386 (2016)
"); document.write("
"); document.write("
"); document.write("
Szentes,\ B.L.\ ; Witt,\ S.\ ; Bush,\ A.*\ ; Cunningham,\ S.*\ ; Emiraliouglu,\ N.*\ ; Goldbeck,\ L.*\ ; Griese,\ M.*\ ; Hengst,\ M.*\ ; Kiper,\ N.*\ ; Krenke,\ K.*\ ; Lange,\ J.*\ ; Leidl,\ R.\ ; Schwerk,\ N.*\ ; Schwarzkopf,\ L.
"); document.write("
Current practice of drug treatment in children with ILD: First insights from the child-EU registry.
"); document.write("
Value Health 19, A558-A558 (2016)
"); document.write("
"); document.write("
"); document.write("
Walter,\ J.\ ; Vogl,\ M.\ ; Holderried,\ M.*\ ; Becker,\ C.\ ; Brandes,\ A.\ ; Sinner,\ M.F.*\ ; Rogowski,\ W.H.\ ; Maschmann,\ J.*
"); document.write("
Manual compression versus vascular closing device for closing access puncture site in femoral left-heart catheterization and percutaneous coronary interventions: A retrospective cross-sectional comparison of costs and effects in inpatient care.
"); document.write("
Value Health 20, 769-776 (2016)
"); document.write("
"); document.write("
"); document.write("
Hoogendoorn,\ M.*\ ; Feenstra,\ T.*\ ; Asukai,\ Y.*\ ; Briggs,\ A.*\ ; Borg,\ S.*\ ; dal Negro,\ R.*\ ; Hansen,\ R.N.*\ ; Jansson,\ S.A.*\ ; Wacker,\ M.\ ; Risebrough,\ N.*\ ; Samyshkin,\ Y.*\ ; Leidl,\ R.\ ; Rutten van-Mölken,\ M.*
"); document.write("
Patient heterogeneity in cost-effectiveness models for Chronic Obstructive Pulmonary Disease (COPD): Are current models suitable to evaluate personalized medicine.
"); document.write("
Value Health 18:A694 (2015)
"); document.write("
"); document.write("
"); document.write("
Laxy,\ M.\ ; Hunger,\ M.\ ; Stark,\ R.G.\ ; Meisinger,\ C.\ ; Kirchberger,\ I.\ ; Heier,\ M.\ ; von Scheidt,\ W.*\ ; Holle,\ R.
"); document.write("
The burden of diabetes mellitus in patients with coronary heart disease: A methodological approach to assess quality-adjusted life-years based on individual-level longitudinal survey data.
"); document.write("
Value Health 18, 969-976 (2015)
"); document.write("
"); document.write("
"); document.write("
Brandes,\ A.\ ; Koerber,\ F.\ ; Schwarzkopf,\ L.\ ; Hunger,\ M.\ ; Waidelich,\ R.*\ ; Rogowski,\ W.H.
"); document.write("
Cost-effectiveness of radical prostatectomy, radiation therapy and active surveillance for the treatment of localized prostate cancer - a claims data analysis.
"); document.write("
Value Health 17, A636-A637 (2014)
"); document.write("
"); document.write("
"); document.write("
Butzke,\ B.\ ; Oduncu,\ F.*\ ; Heinemann,\ V.*\ ; Pfeufer,\ A.\ ; Giessen,\ C.*\ ; Stollenwerk,\ B.\ ; Rogowski,\ W.H.
"); document.write("
Cost-effectiveness analysis of ugt1a1 genotyping before colorectal cancer treatment with irinotecan.
"); document.write("
Value Health 17, A643 (2014)
"); document.write("
"); document.write("
"); document.write("
Hoogendoorn,\ M.*\ ; Feenstra,\ T.L.*\ ; Asukai,\ Y.*\ ; Borg,\ S.*\ ; Hansen,\ R.N.*\ ; Jansson,\ S.A.*\ ; Samyshkin,\ Y.*\ ; Wacker,\ M.\ ; Briggs,\ A.H.*\ ; Lloyd,\ A.*\ ; Sullivan,\ S.D.*\ ; Rutten-van Mölken,\ M.P.*
"); document.write("
Cost-effectiveness models for chronic obstructive pulmonary disease: Cross-model comparison of hypothetical treatment scenarios.
"); document.write("
Value Health 17, 525-536 (2014)
"); document.write("
"); document.write("
"); document.write("
Hoogendoorn,\ M.*\ ; Feenstra,\ T.*\ ; Asukai,\ Y.*\ ; Borg,\ S.*\ ; Hansen,\ R.N.*\ ; Jansson,\ S.A.*\ ; Samyshkin,\ Y.*\ ; Wacker,\ M.\ ; Briggs,\ A.*\ ; Lloyd,\ A.*\ ; Sullivan,\ S.D.*\ ; Rutten-van Moelken,\ M.P.*
"); document.write("
Cost-effectiveness models for Chronic Obstructive Pulmonary Disease (COPD): Cross-model comparison of hypothetical treatment scenarios.
"); document.write("
Value Health 17, A557-A558 (2014)
"); document.write("
"); document.write("
"); document.write("
Laxy,\ M.\ ; Hunger,\ M.\ ; Thorand,\ B.\ ; Meisinger,\ C.\ ; Kirchberger,\ I.*\ ; Holle,\ R.
"); document.write("
The intermediate burden of diabetes mellitus in patients with cardiovascular disease (CVD): A quality adjusted life year (QALY) - analysis based on primary longitudinal data.
"); document.write("
Value Health 17, A494 (2014)
"); document.write("
"); document.write("
"); document.write("
Little,\ M.H.R.\ ; Reitmeir,\ P.\ ; Peters,\ A.\ ; Leidl,\ R.
"); document.write("
The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
"); document.write("
Value Health 17, 364-371 (2014)
"); document.write("
"); document.write("
"); document.write("
Rochau,\ U.*\ ; Kuhner,\ F.*\ ; Jahn,\ B.*\ ; Kurzthaler,\ C.*\ ; Ramos,\ C.*\ ; Chhatwal,\ J.*\ ; Stollenwerk,\ B.\ ; Goldhaber-Fiebert,\ J.D.*\ ; Siebert,\ U.*
"); document.write("
Prioritization of future outcomes research studies in chronic myeloid leukemia: Value of information analysis.
"); document.write("
Value Health 17, A639 (2014)
"); document.write("
"); document.write("
"); document.write("
Leidl,\ R.\ ; Reitmeir,\ P.\ ; König,\ H.-H.*\ ; Stark,\ R.G.
"); document.write("
The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease.
"); document.write("
Value Health 15, 151-157 (2012)
"); document.write("
"); document.write("
"); document.write("
Menn,\ P.\ ; Holle,\ R.\ ; Kunz,\ S.\ ; Donath,\ C.*\ ; Lauterberg,\ J.*\ ; Leidl,\ R.\ ; Marx,\ P.*\ ; Mehlig,\ H.*\ ; Ruckdäschel,\ S.*\ ; Vollmar,\ H.C.*\ ; Wunder,\ S.*\ ; Gräßel,\ E.*
"); document.write("
Dementia care in the general practice setting: A cluster randomized trial on the effectiveness and cost impact of three management strategies.
"); document.write("
Value Health 15, 851-859 (2012)
"); document.write("
"); document.write("
"); document.write("
Rottenkolber,\ D.\ ; Hasford,\ J.*\ ; Stausberg,\ J.*
"); document.write("
Costs of adverse drug events in German hospitals - a microcosting study.
"); document.write("
Value Health 15, 868-875 (2012)
"); document.write("
"); document.write("
"); document.write("
Hunger,\ M.\ ; Baumert,\ J.J.\ ; Holle,\ R.
"); document.write("
Analysis of SF-6D index data: Is beta regression appropriate?
"); document.write("
Value Health 14, 759-767 (2011)
"); document.write("
"); document.write("
"); document.write("
Schwarzkopf,\ L.\ ; Menn,\ P.\ ; Kunz,\ S.\ ; Holle,\ R.\ ; Lauterberg,\ J.*\ ; Marx,\ P.*\ ; Mehlig,\ H.*\ ; Wunder,\ S.*\ ; Leidl,\ R.\ ; Donath,\ C.*\ ; Graessel,\ E.*
"); document.write("
Costs of care for dementia patients in community setting: An analysis for mild and moderate disease stage.
"); document.write("
Value Health 14, 827-835 (2011)
"); document.write("
"); document.write("
"); document.write("
Schweikert,\ B.*\ ; John,\ J.\ ; Ringborg,\ A.*\ ; Erhardt,\ W.*\ ; Bleckmann,\ A.*\ ; Neubauer,\ A.S.*
"); document.write("
Standards for the assessment of antidiabetic drugs-the IQWIG perspectice.
"); document.write("
Value Health 13, A300-A300 (2010)
"); document.write("
"); document.write("
"); document.write("
Happich,\ M.\ ; Moock,\ J.*\ ; von Lengerke,\ T.
"); document.write("
Health state valuation methods and reference points: The case of tinnitus.
"); document.write("
Value Health 12, 88-95 (2009)
"); document.write("
"); document.write("
"); document.write("
Graf von der Schulenburg,\ J.M.*\ ; Greiner,\ W.*\ ; Jost,\ F.*\ ; Klusen,\ N.*\ ; Kubin,\ M.*\ ; Leidl,\ R.\ ; Mittendorf,\ T.*\ ; Rebscher,\ H.*\ ; Schoeffski,\ O.*\ ; Vauth,\ C.*\ ; Volmer,\ T.*\ ; Wahler,\ S.*\ ; Wasem,\ J.*\ ; Weber,\ C.*\ ; Hanover Consensus Group (*)
"); document.write("
German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus.
"); document.write("
Value Health 11, 539-544 (2008)
"); document.write("
");